208 related articles for article (PubMed ID: 10833107)
1. Mycophenolate mofetil for primary biliary cirrhosis--convergent thinking.
Altschuler EL
Eur J Gastroenterol Hepatol; 2000 May; 12(5):587. PubMed ID: 10833107
[No Abstract] [Full Text] [Related]
2. Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
Kaplan MM; Bonis PA
Gastroenterol Clin Biol; 2010; 34(4-5):239-41. PubMed ID: 20462715
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Treiber G; Malfertheiner P
J Clin Gastroenterol; 2005 Oct; 39(9):837-8; author reply 838. PubMed ID: 16145353
[No Abstract] [Full Text] [Related]
4. Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis.
Jones EA; ten Kate FJ; ter Borg F; Houben M; Reesink HW; Chamuleau RA
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1165-9. PubMed ID: 10524648
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Talwalkar JA; Angulo P; Keach JC; Petz JL; Jorgensen RA; Lindor KD
J Clin Gastroenterol; 2005 Feb; 39(2):168-71. PubMed ID: 15681915
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone.
Rabahi N; Chrétien Y; Gaouar F; Wendum D; Serfaty L; Chazouillères O; Corpechot C; Poupon R
Gastroenterol Clin Biol; 2010; 34(4-5):283-7. PubMed ID: 20417047
[TBL] [Abstract][Full Text] [Related]
7. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
Kaplan MM; Poupon R
Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
[No Abstract] [Full Text] [Related]
8. Search for medical treatment for primary biliary cirrhosis.
LaRusso N
Lancet; 1997 Oct; 350(9084):1046. PubMed ID: 10213545
[No Abstract] [Full Text] [Related]
9. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
[TBL] [Abstract][Full Text] [Related]
10. Low-dose methotrexate in primary biliary cirrhosis.
Bonis PA; Kaplan MM
Gastroenterology; 1999 Dec; 117(6):1510-3. PubMed ID: 10610345
[No Abstract] [Full Text] [Related]
11. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid for primary biliary cirrhosis.
Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
[No Abstract] [Full Text] [Related]
13. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
[No Abstract] [Full Text] [Related]
14. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Makino I
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
[No Abstract] [Full Text] [Related]
15. Post-liver transplantation de novo hepatitis with overlap features.
Keaveny AP; Gordon FD; Khettry U
Pathol Int; 2005 Oct; 55(10):660-4. PubMed ID: 16185298
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for primary biliary cirrhosis: who is to be trusted?
Selmi C; Podda M
Dig Dis Sci; 2010 Nov; 55(11):3013-5. PubMed ID: 20945095
[No Abstract] [Full Text] [Related]
17. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
Lim AG; Wolfhagen FH; Verma A; van Buuren HR; Jazrawi RP; Levy JH; Northfield TC; Schalm SW
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):155-61. PubMed ID: 9058626
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
19. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
20. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
Poupon R; Chrétien Y; Chazouillères O; Poupon RE
J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
